BRIEF-Allergan says FDA accepts supplemental new drug application for avycaz
October 11, 2016 at 08:17 AM EDT
* FDA accepts supplemental new drug application (SNDA) for avycaz (ceftazidime and avibactam)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.